NEW YORK (GenomeWeb) — HiberGene Diagnostics said today that it has secured a non-exclusive license to use Eiken Chemical's loop-mediated isothermal amplification (LAMP) technology.

Specifically, Dublin-based HiberGene gains the rights to develop, manufacture, and market diagnostic products for human infectious diseases using LAMP in exchange for an undisclosed license fee and royalty payments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.